Learning and memory deficits in AD have been attributed to a loss of cholinergic transmission that are treated clinically with acetylcholinesterase inhibitors (e.g., donepezil) (Bartus et al., 1982; Francis et al., 1999). This evidence concerns the gene ACHE and Alzheimer disease.